News
PACB
1.350
-8.16%
-0.120
Here's Why You Should Add Cardinal Health Stock to Your Portfolio Now
NASDAQ · 1d ago
GRAIL Partners With Epic to Broaden Galleri Test Access Across US
NASDAQ · 1d ago
Weekly Report: what happened at PACB last week (0330-0403)?
Weekly Report · 4d ago
Gitlab, Altimmune, Cheniere, Pacific Biosciences, Hercules Shock Wall Street
TipRanks · 5d ago
Pacific Biosciences Rocked by Major Insider Sale From Top Executive
TipRanks · 6d ago
Weekly Report: what happened at PACB last week (0323-0327)?
Weekly Report · 03/30 10:13
Pacific Biosciences of California (PACB) Registers a Bigger Fall Than the Market: Important Facts to Note
NASDAQ · 03/27 22:15
Azenta, 10x Genomics, PacBio, Oscar Health, and Moderna Shares Plummet, What You Need To Know
Barchart · 03/27 13:16
PacBio Wins Basecamp Research Deal for Trillion Gene Atlas Initiative
NASDAQ · 03/26 13:05
Weekly Report: what happened at PACB last week (0316-0320)?
Weekly Report · 03/23 10:09
Positioning PacBio for Scalable Growth: SPRQ-Nx, Reusable SMRT Cells, and the Trillion Gene Atlas as Key 2026–2027 Catalysts
TipRanks · 03/19 10:56
PacBio HiFi selected by Basecamp Research AI lab
TipRanks · 03/18 13:10
Basecamp Research selects PacBio HiFi sequencing for Trillion Gene Atlas initiative
Reuters · 03/18 13:05
Fortrea, Alignment Healthcare, PacBio, DexCom, and Humana Stocks Trade Up, What You Need To Know
Barchart · 03/16 15:20
Weekly Report: what happened at PACB last week (0309-0313)?
Weekly Report · 03/16 10:09
PACBIO <PACB.O>: BARCLAYS CUTS TARGET PRICE TO $1.5 FROM $2
Reuters · 03/09 10:23
Weekly Report: what happened at PACB last week (0302-0306)?
Weekly Report · 03/09 10:09
U.S. RESEARCH ROUNDUP-Dow, Oracle, Shopify
Reuters · 03/09 07:34
Pacific Biosciences Secures Key Patent License, Ends Litigation
TipRanks · 03/06 21:34
Pacific Biosciences Settles PGI Patent Litigation in $23M Deal
Reuters · 03/06 21:07
More
Webull provides a variety of real-time PACB stock news. You can receive the latest news about Pacific Biosc through multiple platforms. This information may help you make smarter investment decisions.
About PACB
Pacific Biosciences of California, Inc. is a life science technology company. The Company designs, develops, and manufactures sequencing solutions. Its products and technology include HiFi long-read sequencing technology, which addresses a set of applications including human germline sequencing, plant and animal sciences, infectious disease, microbiology, oncology, and other applications. Its sequencing technology supports oncology research by enabling analysis of both deoxyribonucleic acid (DNA) and ribonucleic acid (RNA), providing researchers with insight into cancer biology. It focuses on creating sequencing systems to provide customers with a view of genomes, transcriptomes, and epigenomes. Its customers include academic and governmental research institutions, commercial testing and service laboratories, genome centers, public health labs, hospitals and clinical research institutes, contract research organizations (CROs), pharmaceutical companies, and agricultural companies.